Kowal Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.36M Buy
1,531
+244
+19% +$219K 0.25% 60
2024
Q2
$1.17M Buy
1,287
+184
+17% +$147K 0.23% 65
2024
Q1
$858K Buy
1,103
+172
+18% +$122K 0.19% 73
2023
Q4
$543K Buy
931
+44
+5% +$25.7K 0.13% 89
2023
Q3
$477K Buy
887
+155
+21% +$79.9K 0.13% 88
2023
Q2
$343K Buy
732
+90
+14% +$37.7K 0.09% 109
2023
Q1
$220K Sell
642
-458
-42% -$154K 0.06% 144
2022
Q4
$402K Buy
1,100
+124
+13% +$44K 0.12% 96
2022
Q3
$316K Buy
976
+34
+4% +$10.8K 0.11% 99
2022
Q2
$305K Buy
+942
New +$283K 0.1% 102
2021
Q4
Sell
-516
Closed -$119K 569
2021
Q3
$119K Buy
+516
New +$127K 0.04% 134

Other funds holding LLY

Kowal Investment Group's LLY Position: Q3 2024 in Review

Kowal Investment Group increased its Eli Lilly (LLY) stake by 19% in Q3 2024, buying an estimated $219K and bringing the position to 1,531 shares worth $1.36M. The position accounts for 0.25% of the portfolio, ranked #60.

Kowal Investment Group first reported a position in LLY in Q3 2021 and has held it in 11 quarters since. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Kowal Investment Group held 1,531 shares of Eli Lilly worth $1.36M as of Q3 2024.
  • Kowal Investment Group bought 244 Eli Lilly shares in Q3 2024, an estimated $219K.
  • Eli Lilly made up 0.25% of Kowal Investment Group's portfolio in Q3 2024, its #60 holding.
  • Kowal Investment Group first reported a position in Eli Lilly in Q3 2021 and has held it in 11 quarters since.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Kowal Investment Group's 13F filing for Q3 2024, filed 16 Oct 2024.